StreetInsider.com News Articles

Form SC 13D COSCIENS Biopharma Inc. Filed by: Goodwood Inc.

Fri, 06 Sep 2024 14:05:00 -0400

si-local-file:///var/storage/secattach/20240906/23697242.html

Form SC 13D COSCIENS Biopharma Inc. Filed by: Goodwood Inc.

Fri, 06 Sep 2024 14:05:00 -0400

si-local-file:///var/storage/secattach/20240906/23697242.html

Form SC 13D COSCIENS Biopharma Inc. Filed by: Goodwood Inc.

Fri, 06 Sep 2024 14:05:00 -0400

si-local-file:///var/storage/secattach/20240906/23697242.html

Form 6-K COSCIENS Biopharma Inc. For: Aug 27

Tue, 27 Aug 2024 07:30:00 -0400

si-local-file:///var/storage/secattach/20240827/23646876.html

Form 6-K COSCIENS Biopharma Inc. For: Aug 27

Tue, 27 Aug 2024 07:30:00 -0400

si-local-file:///var/storage/secattach/20240827/23646876.html

Form 6-K COSCIENS Biopharma Inc. For: Aug 27

Tue, 27 Aug 2024 07:30:00 -0400

si-local-file:///var/storage/secattach/20240827/23646876.html

Form 6-K COSCIENS Biopharma Inc. For: Jun 30

Tue, 13 Aug 2024 08:06:00 -0400

si-local-file:///var/storage/secattach/20240813/23589539.html

Form 6-K COSCIENS Biopharma Inc. For: Jun 30

Tue, 13 Aug 2024 08:06:00 -0400

si-local-file:///var/storage/secattach/20240813/23589539.html

Form 6-K COSCIENS Biopharma Inc. For: Jun 30

Tue, 13 Aug 2024 08:06:00 -0400

si-local-file:///var/storage/secattach/20240813/23589539.html

Form 6-K COSCIENS Biopharma Inc. For: Aug 13

Tue, 13 Aug 2024 08:05:00 -0400

si-local-file:///var/storage/secattach/20240813/23589533.html

Form 6-K COSCIENS Biopharma Inc. For: Aug 13

Tue, 13 Aug 2024 08:05:00 -0400

si-local-file:///var/storage/secattach/20240813/23589533.html

Form 6-K COSCIENS Biopharma Inc. For: Aug 13

Tue, 13 Aug 2024 08:05:00 -0400

si-local-file:///var/storage/secattach/20240813/23589533.html

Form 6-K Aeterna Zentaris Inc. For: Aug 06

Wed, 07 Aug 2024 06:01:00 -0400

si-local-file:///var/storage/secattach/20240807/23561638.html

Form 6-K Aeterna Zentaris Inc. For: Aug 06

Wed, 07 Aug 2024 06:01:00 -0400

si-local-file:///var/storage/secattach/20240807/23561638.html

Form 6-K Aeterna Zentaris Inc. For: Aug 06

Wed, 07 Aug 2024 06:01:00 -0400

si-local-file:///var/storage/secattach/20240807/23561638.html

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

Tue, 06 Aug 2024 18:00:00 -0400

TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) ("COSCIENS" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries, today announces that the Company’s name has been changed from “Aeterna Zentaris Inc.” to “COSCIENS Biopharma Inc.”, effective as of August 6, 2024 (the “Name Change”).

In addition, the

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

Tue, 06 Aug 2024 18:00:00 -0400

In addition, the

Form 20-F/A Aeterna Zentaris Inc. For: Dec 31

Wed, 17 Jul 2024 06:03:00 -0400

si-local-file:///var/storage/secattach/20240717/23471613.html

Form 20-F/A Aeterna Zentaris Inc. For: Dec 31

Wed, 17 Jul 2024 06:03:00 -0400

si-local-file:///var/storage/secattach/20240717/23471613.html

Form 6-K Aeterna Zentaris Inc. For: Jul 16

Wed, 17 Jul 2024 06:01:00 -0400

si-local-file:///var/storage/secattach/20240717/23471485.html

Form 6-K Aeterna Zentaris Inc. For: Jul 16

Wed, 17 Jul 2024 06:01:00 -0400

si-local-file:///var/storage/secattach/20240717/23471485.html

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

Tue, 16 Jul 2024 16:05:00 -0400

TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries, today announced the voting results on the items of business considered at the virtual annual general and special meeting of shareholders of the Company (the "AGSM") held today.

Results of the AGSM

The results

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

Tue, 16 Jul 2024 16:05:00 -0400

Results of the AGSM

The results

Mannatech Announces Appointment of James Clavijo as Chief Financial Officer

Mon, 01 Jul 2024 17:46:00 -0400

FLOWER MOUND, Texas--(BUSINESS WIRE)-- Mannatech, Incorporated (NASDAQ: MTEX) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024.

James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical commercialization and manufacturing, has negotiated licensing and

Mannatech Announces Appointment of James Clavijo as Chief Financial Officer

Mon, 01 Jul 2024 17:46:00 -0400